AVE Science & Technology Co Ltd (688067) — Capital Reinvestment Ratio

Latest as of September 2025: 0.06x

AVE Science & Technology Co Ltd (688067) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥15.02 Million) in capital expenditures (CN¥922.05K). See 688067 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥15.02 Million
CNY

Capital Expenditures

CN¥922.05K
CNY

Data as of

Sep 2025
Most recent filing

AVE Science & Technology Co Ltd Capital Reinvestment Ratio (2012–2024)

This chart tracks AVE Science & Technology Co Ltd's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for AVE Science & Technology Co Ltd (2012–2024)

Year-by-year Capital Reinvestment Ratio for AVE Science & Technology Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see AVE Science & Technology Co Ltd (688067) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.17x CN¥22.41 Million CN¥3.75 Million ▼ -15.4%
2023 0.20x CN¥22.73 Million CN¥4.50 Million ▼ -72.2%
2022 0.71x CN¥29.74 Million CN¥21.20 Million ▲ +64.0%
2021 0.43x CN¥47.19 Million CN¥20.52 Million ▲ +72.9%
2020 0.25x CN¥46.93 Million CN¥11.80 Million ▼ -36.2%
2019 0.39x CN¥62.10 Million CN¥24.49 Million ▼ -8.4%
2018 0.43x CN¥40.36 Million CN¥17.37 Million ▼ -77.8%
2017 1.94x CN¥24.76 Million CN¥48.06 Million ▲ +169.5%
2016 0.72x CN¥31.19 Million CN¥22.46 Million ▼ -13.7%
2015 0.83x CN¥21.35 Million CN¥17.82 Million ▼ -49.5%
2014 1.65x CN¥23.43 Million CN¥38.72 Million ▲ +230.2%
2013 0.50x CN¥14.87 Million CN¥7.44 Million ▼ -61.4%
2012 1.30x CN¥13.53 Million CN¥17.56 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow